BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boulos LJ, Ben Hamida S, Bailly J, Maitra M, Ehrlich AT, Gavériaux-Ruff C, Darcq E, Kieffer BL. Mu opioid receptors in the medial habenula contribute to naloxone aversion. Neuropsychopharmacology 2020;45:247-55. [PMID: 31005059 DOI: 10.1038/s41386-019-0395-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Mu R, Tang S, Han X, Wang H, Yuan D, Zhao J, Long Y, Hong H. A cholinergic medial septum input to medial habenula mediates generalization formation and extinction of visual aversion. Cell Rep 2022;39:110882. [PMID: 35649349 DOI: 10.1016/j.celrep.2022.110882] [Reference Citation Analysis]
2 Chen M, Wu S, Tang P. Acupuncture plus naloxone hydrochloride in the treatment of coma after surgery for cerebral hemorrhage: a randomized controlled trial. J Acupunct Tuina Sci 2022;20:134-8. [DOI: 10.1007/s11726-022-1304-x] [Reference Citation Analysis]
3 Kang W, Liu S, Xu J, Abrimian A, Malik AF, Chien R, Adaralegbe A, Amponsah A, Cartegni L, Pintar J, Pan YX. Exploring Pharmacological Functions of Alternatively Spliced Variants of the Mu Opioid Receptor Gene, Oprm1, via Gene-Targeted Animal Models. Int J Mol Sci 2022;23:3010. [PMID: 35328429 DOI: 10.3390/ijms23063010] [Reference Citation Analysis]
4 Dodu JC, Moncayo RK, Damaj MI, Schlosburg JE, Akbarali HI, O'Brien LD, Kendall DA, Wu Z, Lu D, Lichtman AH. The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice. J Pharmacol Exp Ther 2022;380:1-14. [PMID: 34625464 DOI: 10.1124/jpet.121.000723] [Reference Citation Analysis]
5 Han J, Andreu V, Langreck C, Pekarskaya EA, Grinnell SG, Allain F, Magalong V, Pintar J, Kieffer BL, Harris AZ, Javitch JA, Hen R, Nautiyal KM. Mu opioid receptors on hippocampal GABAergic interneurons are critical for the antidepressant effects of tianeptine. Neuropsychopharmacology 2021. [PMID: 34593976 DOI: 10.1038/s41386-021-01192-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ranjbar H, Soti M, Banazadeh M, Saleki K, Kohlmeier KA, Shabani M. Addiction and the cerebellum with a focus on actions of opioid receptors. Neurosci Biobehav Rev 2021;131:229-47. [PMID: 34555385 DOI: 10.1016/j.neubiorev.2021.09.021] [Reference Citation Analysis]
7 Shokri-Kojori E, Wang GJ, Volkow ND. Naloxone precipitated withdrawal increases dopamine release in the dorsal striatum of opioid dependent men. Transl Psychiatry 2021;11:445. [PMID: 34471102 DOI: 10.1038/s41398-021-01548-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Cooper AH, Hedden NS, Corder G, Lamerand SR, Donahue RR, Morales-Medina JC, Selan L, Prasoon P, Taylor BK. Endogenous µ-opioid receptor activity in the lateral and capsular subdivisions of the right central nucleus of the amygdala prevents chronic postoperative pain. J Neurosci Res 2021. [PMID: 33957003 DOI: 10.1002/jnr.24846] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Reeves KC, Kube MJ, Grecco GG, Fritz BM, Muñoz B, Yin F, Gao Y, Haggerty DL, Hoffman HJ, Atwood BK. Mu opioid receptors on vGluT2-expressing glutamatergic neurons modulate opioid reward. Addict Biol 2021;26:e12942. [PMID: 32686251 DOI: 10.1111/adb.12942] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
10 Ehrlich AT, Darcq E. Recent advances in basic science methodology to evaluate opioid safety profiles and to understand opioid activities. Fac Rev 2021;10:15. [PMID: 33718932 DOI: 10.12703/r/10-15] [Reference Citation Analysis]
11 Sivalingam M, Ogawa S, Parhar IS. Habenula kisspeptin retrieves morphine impaired fear memory in zebrafish. Sci Rep 2020;10:19569. [PMID: 33177592 DOI: 10.1038/s41598-020-76287-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Severino AL, Mittal N, Hakimian JK, Velarde N, Minasyan A, Albert R, Torres C, Romaneschi N, Johnston C, Tiwari S, Lee AS, Taylor AM, Gavériaux-Ruff C, Kieffer BL, Evans CJ, Cahill CM, Walwyn WM. μ-Opioid Receptors on Distinct Neuronal Populations Mediate Different Aspects of Opioid Reward-Related Behaviors. eNeuro 2020;7:ENEURO. [PMID: 32859725 DOI: 10.1523/ENEURO.0146-20.2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
13 Vickstrom CR, Liu X, Zhang Y, Mu L, Kelly TJ, Yan X, Hu MM, Snarrenberg ST, Liu QS. T-Type Calcium Channels Contribute to Burst Firing in a Subpopulation of Medial Habenula Neurons. eNeuro 2020;7:ENEURO. [PMID: 32719103 DOI: 10.1523/ENEURO.0201-20.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zhang XY, Li Q, Dong Y, Yan W, Song K, Lin YQ, Sun YG. Mu-Opioid Receptors Expressed in Glutamatergic Neurons are Essential for Morphine Withdrawal. Neurosci Bull 2020;36:1095-106. [PMID: 32451910 DOI: 10.1007/s12264-020-00515-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Otsu Y, Darcq E, Pietrajtis K, Mátyás F, Schwartz E, Bessaih T, Abi Gerges S, Rousseau CV, Grand T, Dieudonné S, Paoletti P, Acsády L, Agulhon C, Kieffer BL, Diana MA. Control of aversion by glycine-gated GluN1/GluN3A NMDA receptors in the adult medial habenula. Science 2019;366:250-4. [PMID: 31601771 DOI: 10.1126/science.aax1522] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 12.5] [Reference Citation Analysis]
16 Reiss D, Maduna T, Maurin H, Audouard E, Gaveriaux-Ruff C. Mu opioid receptor in microglia contributes to morphine analgesic tolerance, hyperalgesia, and withdrawal in mice. J Neurosci Res 2020. [PMID: 32253777 DOI: 10.1002/jnr.24626] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Lüscher C, Robbins TW, Everitt BJ. The transition to compulsion in addiction. Nat Rev Neurosci 2020;21:247-63. [PMID: 32231315 DOI: 10.1038/s41583-020-0289-z] [Cited by in Crossref: 72] [Cited by in F6Publishing: 55] [Article Influence: 36.0] [Reference Citation Analysis]
18 Klein ME, Chandra J, Sheriff S, Malinow R. Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents. Proc Natl Acad Sci U S A 2020;117:2656-62. [PMID: 31941713 DOI: 10.1073/pnas.1916570117] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 16.5] [Reference Citation Analysis]
19 Metzger M, Souza R, Lima LB, Bueno D, Gonçalves L, Sego C, Donato J Jr, Shammah-Lagnado SJ. Habenular connections with the dopaminergic and serotonergic system and their role in stress-related psychiatric disorders. Eur J Neurosci 2021;53:65-88. [PMID: 31833616 DOI: 10.1111/ejn.14647] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
20 Welsch L, Bailly J, Darcq E, Kieffer BL. The Negative Affect of Protracted Opioid Abstinence: Progress and Perspectives From Rodent Models. Biol Psychiatry 2020;87:54-63. [PMID: 31521334 DOI: 10.1016/j.biopsych.2019.07.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
21 Fox ME. Aversion No MOR: Mu-opioid receptors in habenular β4 neurons are key for naloxone aversion. Neuropsychopharmacology 2020;45:243-4. [PMID: 31055593 DOI: 10.1038/s41386-019-0404-x] [Reference Citation Analysis]